If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank 144a Regulatory News (AXBA)

Share Price Information for Axis Bank 144a (AXBA)

Share Price is delayed by 15 minutes
Get Live Data
40.9145    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $25.46b
AXBA Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank 144a Share Chart

Change in Management

17 Jan 2025 14:46

RNS Number : 8164T
Axis Bank Limited
17 January 2025
 

AXIS/CO/CS/597/2024-25

 

January 17, 2025

 

 

Dear Sir/Madam,

 

REF.:

DISCLOSURE UNDER REGULATIONS 30 OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 ("SEBI LISTING REGULATIONS")

 

SUB.:

RE-APPOINTMENT OF PROF. S. MAHENDRA DEV AS INDEPENDENT DIRECTOR OF AXIS BANK LIMITED

 

This is to inform you that in terms of the applicable laws and based on the recommendation of the Nomination and Remuneration Committee of Directors, the Board of Directors at its meeting held today, i.e., Friday, January 17, 2025, approved the re-appointment of Prof. S. Mahendra Dev as an Independent Director of the Bank, for second term of four years effective from June 14, 2025 to June 13, 2029 (both days inclusive), subject to approval of the members of the Bank.

 

Please note that Prof. S. Mahendra Dev is not debarred from holding the office of a director, by virtue of any SEBI order or any other such authority.

 

The details required as per SEBI circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed as Annexure A.

 

You are requested to take the above on record and bring this to the notice of all concerned.

 

Thanking You.

 

Yours faithfully,

 

For Axis Bank Limited

 

 

Sandeep Poddar

Company Secretary

 

Encl: as above

CC: 

London Stock Exchange

Singapore Stock Exchange

 

Annexure A

 

Sr No.

Particulars

Prof. S. Mahendra Dev

1

Reason for Change

Re- appointment

2

Date of re-appointment & term of re-appointment

Four years effective from June 14, 2025 to June 13, 2029 (both days inclusive).

3

Brief profile

Prof. S. Mahendra Dev, age 67 years, is the Chairman of the Institute for Development Studies, Andhra Pradesh, Visakhapatnam, since February 26, 2022.

 

Prior to this position, he was the Director and Vice Chancellor of Indira Gandhi Institute of Development Research from 2010 to 2022, Chairman of the Commission for Agricultural Costs and Prices, Ministry of Agriculture from 2008 to 2010. He was Vice Chairman of the Board of Trustees of International Food Policy Research Institute (IFPRI), Washington, D.C. He was also member of the Board of IFPRI for seven years from 2013 to 2019. He was member and Acting Chairman of the National Statistical Commission, Government of India. He got the prestigious Malcolm Adiseshiah Award in 2016. He was Director, Centre for Economic and Social Studies, Hyderabad, India for 9 years from 1999 to 2008. He was independent director of the Board of Kotak Mahindra Bank for 8 years during March 15, 2013 to March 14, 2021 and independent director of Kotak Mahindra Prime Ltd., during March 30, 2015 to June 2, 2021.

 

He is an expert on agriculture and rural economy, economics and cooperation. He received his Ph.D. from the Delhi School of Economics and did his postdoctoral research at Yale University. His main areas of interest are agriculture, rural economy, rural non-farm sector, cooperation, economic growth, global economy, macro policies, employment and unemployment, employment policies, social protection, development economics and social sector.

 

He has around 200 research publications in national and international journals in the areas of agricultural development, poverty and public policy, inequality, food security, nutrition, employment guarantee schemes, social security, farm and nonfarm employment. He has written or edited 19 books. His well cited publication is "Inclusive Growth in India: Agriculture, Poverty, and Human Development" published by Oxford University Press. His book "Perspectives on Equitable Development" was released by the former Prime Minister of India.

4

Disclosure of

relationship between

directors

Prof S. Mahendra Dev is not related to any other Directors or Key Managerial Personnel of the Bank.

 

http://www.rns-pdf.londonstockexchange.com/rns/8164T_1-2025-1-17.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFLFDWEISEEF
Date   Source Headline
21st Oct 20222:57 pmRNSRATING ACTION BY FITCH RATINGS
21st Oct 202211:40 amRNSRe-appointment of Chief Risk Officer
20th Oct 20222:24 pmRNSAppointment of Additional Independent Director
20th Oct 202212:49 pmRNSOutcome of Board Meeting - October 20, 2022
4th Aug 20223:46 pmRNSUpdate on Sale of Axis Bank UK Limited
2nd Aug 202212:08 pmRNSRegulation 30 - Disclosure of SEBI(LODR) Reg, 2015
29th Jul 20221:53 pmRNSOutcome of Annual General Meeting - July 29, 2022
26th Jul 20222:35 pmRNSApproval of Competition Commission of India
25th Jul 202212:33 pmRNSOutcome of Board meeting
20th Jul 20226:17 pmRNSIntimation of Earnings Call
12th Jul 20225:22 pmRNSRe-appointment of Chairman of the Bank
6th Jul 20228:27 amRNSBoard Meeting Intimation
5th Jul 20229:21 amRNSNOTICE OF 28TH ANNUAL GENERAL MEETING
24th Jun 20224:39 pmRNSRe-appointment of Deputy Managing Director
20th Jun 20222:39 pmRNSMOODY’S INVESTORS SERVICE RATING ACTION
16th Jun 20227:00 amRNSCredit Rating
1st Jun 20226:01 pmRNSCredit Rating
12th May 202210:11 amRNSCredit Rating Action
29th Apr 20221:48 pmRNSOutcome of Board Meeting - April 29, 2022
28th Apr 20222:57 pmRNSDisclosure of Related Party Transactions
28th Apr 202212:51 pmRNSOutcome of Board Meeting held on April 28, 2022
25th Apr 20221:44 pmRNSEarnings call intimation
11th Apr 20223:54 pmRNSPostal Ballot Results
8th Apr 20225:12 pmRNSRATING ACTION BY CARE RATINGS LIMITED
8th Apr 20221:02 pmRNSINTIMATION FOR BOARD MEETING
7th Apr 20221:26 pmRNSRATING ACTION BY CRISIL RATINGS LIMITED
30th Mar 20221:04 pmRNSPurchase of Citibank’s India Consumer Business
29th Mar 202210:34 amRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
28th Mar 20222:23 pmRNSAmendments to Fair Disclosure Code
22nd Mar 20222:38 pmRNSGrant of Stock Options
7th Mar 20223:19 pmRNSResults of Postal Ballot
4th Feb 20227:00 amRNSNotice of postal ballot
24th Jan 202212:36 pmRNSFinancial Results for quarter - December 31, 2021
18th Jan 20222:23 pmRNSEarnings Call - Update on Financial Results
10th Jan 20221:00 pmRNSAppointment of Company Secretary
10th Jan 202212:58 pmRNSRe-appointment of Deputy Managing Director
29th Dec 20217:00 amRNSRE-DESIGNATION
22nd Dec 202111:28 amRNSAllotment of Securities
21st Dec 20217:00 amRNSReclassification of Promoter
20th Dec 20217:00 amRNSUpdates
20th Dec 20217:00 amRNSCessation of Director
16th Dec 202112:13 pmRNSBoard Meeting to consider Financial Results
15th Dec 20211:58 pmRNSRating Action By Crisil Ratings Limited
15th Dec 20211:46 pmRNSRating action by ICRA Limited
14th Dec 202112:57 pmRNSAppointment of Director
9th Dec 20211:16 pmRNSApproval of Grant of Stock Options
30th Nov 20211:04 pmRNSReclassification of Promoters
30th Nov 20217:00 amRNSFitch Ratings Action
27th Oct 20211:25 pmRNSRe-designation - Deputy Managing Director
26th Oct 20212:17 pmRNSRelated Party Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.